DOCSLIB.ORG

Input Data Aim of Virmap

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Input Data Aim of Virmap Input Data • Next-generation sequencing data • Single-end or paired-end • Mix of viruses, host, bacteria and phage DNA and RNA • Capture sequencing to enrich for viruses Aim of VirMap • Identify reads that map to known viral sequences • De novo sequence assembly and recover putative novel virus sequences • Assign each viral sequence to species (e.g. identify the taxonomy) Instructions for Installation of VirMap on Gadi • Lack of installation instructions (early 2019). Enlisted help from ResTech • Instructions from ResTech: • https://github.com/rsoftone/virmap • Download VirMap pipeline: https://github.com/cmmr/virmap.git Miniconda • Conda modules • (e.g. bbmap, diamond, megahit) • Perl • RocksDB – taxonomy lookup • Recommend not to install in default $TMPDIR (/scratch/projectID/userID/tmp). Please update $TMPDIR with some other location (e.g. export TMPDIR= /g/data/projectID/userID/tmp). Testing VirMap Installation Part 1: Taxonomy database generation • Run script to generate the taxaJson.dat file • The name is misleading - it is not JSON but actually Sereal- encoded, Zstd compressed Perl hash reference built up from NCBI taxonomy files. Code highlights • Download taxonomy data from NCBI • Construct edges to child-nodes from taxonomy data • Sereal encoding + Zstd compression of Perl hash-reference • https://github.com/rsoftone/virmap/tree/master/10- helper-scripts Part 2: Accession -> GI lookup • Downloads a table that converts NCBI accession to GI accession • NCBI accession: NM_000202.5 • GI accession: 262118207 FASTA format header: • blue = fields that are contained in the NCBI Genbank feature table. • yellow = not currently in Genbank’s feature table and need to be obtained via Accession -> GI lookup • Information obtained by correspondence with VirMap authors. Nucleotide: • >gi|2765944|gb|Z99337.1|.Human.immunodeficiency.virus.1.isolate.C49.DNA.for.reverse;taxId=11676 Protein: • >GI|GI:817036220|KR080198.1|AKF14503.1|GI:817036221|hypothetical.protein|Mycobacterium.phage.Ca mbiare;pos=46..537;codonStart=1;taxId=1647305 https://github.com/rsoftone/virmap/tree/master/10-helper-scripts Part 3: Genbank division download • https://github.com/rsoftone/virmap/tree/master/referencedbs • Download aspera fast data transfer (ascp) utility • List files served by GenBank FTP server • Downloading required GenBank divisions • The GenBank database is divided into 18 divisions. For example: • PRI - primate sequences • VRT - other vertebrate sequences • PLN - plant, fungal, and algal sequences • BCT - bacterial sequences • VRL - viral sequences Other Steps for Setting the Database • Part 4: Nucleotide .fasta generation using Gadi PBS script • Part 5: Protein .fasta generation using Gadi PBS script • Part 6: Build BBmap virus database (reads mapping) • Part 7: Build Diamond virus database (protein sequence DB search) • Part 7.5: Build Diamond genbank database (gbBlastx) • Part 8: Build Kraken2 database – find lowest common ancestor (LCA) of all genomes containing the short sequence (k-mer), assign taxonomy to sequence • Part 9: Build blastn genbank database (gbBlastn) Configure virmap_config.sh in the ## Under $TMPDIR/virmap/ virmap_config.sh ## File path, used as the value for the --gbBlastx parameter GB_BLASTX="/g/data1a/projectID/VirMap/200625-gbblastx.dmnd" ## Partial file path, used as the value for the --gbBlastn parameter GB_BLASTN="/g/data1a/projectID/VirMap/191205-gbBlastn/191205-gbBlastn" ## Folder path, used as the value for the --virBbmap parameter VIR_BBMAP="/g/data1a/projectID/VirMap/191205-virBbmap" ## File path, used as the value for the --virDmnd parameter VIR_DMND="/g/data1a/projectID/VirMap/200625-virdiamond.dmnd" ## File path, used as the value for the --taxaJson parameter TAXA_JSON="/g/data1a/projectID/VirMap/200117-taxaJson.dat" Run VirMap Wrapper Script (part 1) # Activate Conda Environment INSTALL_DIR=$TMPDIR/virmap MINICONDA_DIR=$TMPDIR/miniconda3 export TMPDIR= /g/data/projectID/userID/tmp mkdir -p/path/to/store/output cd /path/to/store/output cp $INSTALL_DIR/activate.sh /path/to/store/output source activate.sh Run VirMap Wrapper Script (part 2) qsub -P projectID -q normal -l walltime=6:00:00,\ mem=48G,ncpus=12,wd,jobfs=100GB,storage=scratch/projectID +gdata/projectID -joe -- \ $INSTALL_DIR/virmap_wrapper.sh \ --readUnpaired "/path/to/my/sample/.fastq" \ --sampleName "sample_name" VirMap Output • Final Output file (e.g. nCoV_228_S83_L001_R1_001.final.fa) • Fasta file contained list of all assembled virus genomes and taxonomy information, if available. • Example fasta header: >gi|1369125429|gb|MG772934.1|Bat.SARS-like.coronavirus.isolate.bat-SL- CoVZXC21,.complete.genome.,...;taxId=1508227;length=29566;size=53956; maxScore=9709;maxAlign=9964;maxPossibleScore=15495;protScore=9709; maxProtAlign=9964;nuclScore=0;maxNuclAlign=0;letterOccupancy=71.54;hi ghDivergence=1 Aggregate Results • Give the script a list of results directories and it will aggregate data from running many samples into one Excel file • Whether the run is successful and returned usable results • For each sample • List of viruses, listed by NCBI taxonomy ID • The taxonomy classification hierarchy • De-duplicate read counts https://github.com/rsoftone/virmap/tree/master/aggreg_stats Aggregate number of errors for each sample Walltimes for running each step for individual sample Duration for Each Step 12 cores and 48 Gb Ram 24 cores and 112 Gb RAM Run Statistics • 94 samples from 93 individuals • Two of the 94 samples failed our first attempt at running VirMap • 8 samples failed de-duplication but still produced results • The total amount of SU used by the 92 samples is 5,894 SU • median of 62.5 SU ±2.5 SU standard error (se) per sample • Walltime: • 1:37 ±4 min se. for 12 cores and 48 Gb RAM, and • 1:22 ± 2.3 min. se for 24 cores and 112 Gb RAM Get de-duplicated read counts • In a table format. Columns include: • NCBI tax id (e.g. 1508227) • Size = number of deduplicated reads (e.g. 408) • Weak or strong match, whether the sequence can be assigned to a taxa, potential for mis-annotation etc… • Taxonomy lineage in text. For example: • Viruses -> Riboviria -> Nidovirales -> Cornidovirineae -> Coronaviridae -> Orthocoronavirinae -> Betacoronavirus -> Sarbecovirus -> Severe acute respiratory syndrome-related coronavirus -> Bat SARS-like coronavirus Heat map of 94 samples versus viruses identified – prelim. results Coronaviruses Summary Results • 63/92 (68%) samples had coronavirus of some sort (2019 reference database) as detected by VirMap • 81/92 (88%) samples had other viruses that are not coronaviruses or phage. • 55/92 (59.8%) samples had co-infection of Coronavirus and other viruses. • Endogenous retrovirus K, found, in 89/92 samples, not Coronaviruses shown in heat map Re-map Reads to Viral SeQuences to get Read Counts • Get read counts for each virus • Remove all reads that mapped to • The human genome • Bacterial Genbank division genomes • Bacteriophage Genbank division genomes • Map all remaining reads to the *.final.fa virus genomes assembled from the sample • Remove multi-mapped reads • Get read counts • Usage: ./get_read_counts.sh -g human_genome_bwa -p phage_bwa -b bacteria_bwa virmap_output.final.fa virmap_input_sequence.fq • https://github.com/rsoftone/virmap/blob/master/get_read_counts.sh Availability on Other Platforms • Katana • Duncan has attempted to install VirMap • Differences in CentOS version (Katana v6, Gadi v7) • Conda dependencies in Katana cannot be resolved • Microsoft Azure • VirMap will install in an Ubuntu instance • Need to transfer data into blob storage and transfer output back into blob storage • Around $300 test Credits for UNSW staff and students • Need to submit request for higher capacity machine, contact support. • Remember to switch off the instance when you don’t need it • Amazon • Original VirMap Github currently has instructions on how to install pipeline and reference DB in Amazon. (Was not available before in 2019.) Future Works • Comparison to other tools (e.g. IDSeq and Genome Detective) • Analyze more samples wit VirMap • Update sequence database to 2020 version on Gadi (for COVID19 analysis) • Possible developments: • Option to replace for BlastN with a faster tool MMseqs2 (https://github.com/soedinglab/MMseqs2) • Re-write parts of VirMap in a workflow scripting language (e.g. Snakemake or Nextflow) Acknowledgements UNSW ResTech • Virology Research Laboratory: • Prof. Maria Craig. • Prof. William Rawlinson • Sonia Isaacs (PhD) • Emily Gibson & Cynthia Lau (RA) • Clare Faulkner, Dylan Foskett, Jessica Lau (Students) • Coordinators: Jacki, Deb, Susan, Kelly, Jess • UNSW: • Prof. Marc Wilkins • Dr. Ignatius Pang • A/Prof. Rowena Bull • A/Prof. Fabio Luciani • UNSW ResTech (Simon, David, Martin, Duncan, Robin) • Center for Infection & Immunity: • Prof. Ian Lipkin • A/Prof. Thomas Briese • ENDIA Study: • Prof. Jennifer Couper (CI) • All investigators • Study coordinators • Study team • Microsoft (Andreas Wilm & Auda Eltahla) • Mothers & Children supporting ENDIA • National Collaborative Research Infrastructure Strategy (NCRIS) and Bioplatforms Australia Serology & Taxonomy data from NCBI Notes from Simon. Downloading and unzipping should produce the files: names.dmp nodes.dmp You'll need the following fields from each file, based on the VirMap krakenFilter.pl, which imports the following columns ($parents, $names, $ranks, $children) nodes.dmp tax_id -- node id in GenBank taxonomy database. The ‘children’ needs to be derived from reverse of ‘parents’, so some code is needed to perform this. parent tax_id -- parent node id in GenBank taxonomy database (I think this corresponds to the 'parents' field) rank -- rank of this node (superkingdom, kingdom, ... (I think this corresponds to the 'ranks' field) names.dmp tax_id -- the id of node associated with this name (use this field to merge with the nodes.dmp file) name_txt -- name itself (I think this corresponds to the ‘names’ field)..
Load more

Recommended publications
  • Characterization of the Matrix Proteins of the Fish Rhabdovirus, Infectious Hematopoietic Necrosis Virus
    AN ABSTRACT OF THE THESIS OF Patricia A. Ormonde for the degree of Master of Science presented on April 14. 1995. Title: Characterization of the Matrix Proteins of the Fish Rhabdovinis, Infectious Hematopoietic Necrosis Virus. Redacted for Privacy Abstract approved: Jo-Ann C. ong Infectious hematopoietic necrosis virus (1HNV) is an important fish pathogen enzootic in salmon and trout populations of the Pacific Northwestern United States. Occasional epizootics in fish hatcheries can result in devastating losses of fish stocks. The complete nucleotide sequence of IHNV has not yet been determined. This knowledge is the first step towards understanding the roles viral proteins play in IHNV infection, and is necessary for determining the relatedness of IHNV to other rhabdoviruses. The glycoprotein, nucleocapsid and non-virion genes of IHNV have been described previously; however, at the initiation of this study, very little was known about the matrix protein genes. Rhabdoviral matrix proteins have been found to be important in viral transcription and virion assembly. This thesis describes the preliminary characterization of the M1 and M2 matrix proteins of IHNV. In addition, the trout humoral immune response to M1 and M2 proteins expressed from plasmid DNA injected into the fish was investigated. This work may prove useful in designing future vaccines against IHN. The sequences of M1 phosphoprotein and M2 matrix protein genes of IHNV were determined from both genomic and mRNA clones. Analysis of the sequences indicated that the predicted open reading frame of M1 gene encoded a 230 amino acid protein with a estimated molecular weight of 25.6 kDa. Further analysis revealed a second open reading frame encoding a 42 amino acid protein with a calculated molecular weight of 4.8 kDa.
    [Show full text]
  • Parallels Among Positive-Strand RNA Viruses, Reverse-Transcribing Viruses and Double-Stranded RNA Viruses
    REVIEWS Parallels among positive-strand RNA viruses, reverse-transcribing viruses and double-stranded RNA viruses Paul Ahlquist Abstract | Viruses are divided into seven classes on the basis of differing strategies for storing and replicating their genomes through RNA and/or DNA intermediates. Despite major differences among these classes, recent results reveal that the non-virion, intracellular RNA- replication complexes of some positive-strand RNA viruses share parallels with the structure, assembly and function of the replicative cores of extracellular virions of reverse-transcribing viruses and double-stranded RNA viruses. Therefore, at least four of seven principal virus classes share several underlying features in genome replication and might have emerged from common ancestors. This has implications for virus function, evolution and control. Positive-strand RNA virus Despite continuing advances, established and emerging ssRNA or dsRNA. Other viruses replicate by intercon- A virus, the infectious virions of viruses remain major causes of human disease, with verting their genomes between RNA and DNA. The viri- which contain the genome in a dramatic costs in mortality, morbidity and economic ons of such reverse-transcribing viruses always initially single-stranded, messenger- terms. In addition to acute diseases, viruses cause at package the RNA forms of their genomes, and either sense RNA form. least 15–20% of human cancers1,2 and are implicated in might (for example, hepadnaviruses and foamy retro- neurological and other chronic disorders. One of many viruses) or might not (for example, orthoretroviruses) challenges in controlling viruses and virus-mediated dis- reverse-transcribe the RNA into DNA before the virion eases is that viruses show an amazing diversity in basic exits the initially infected producer cell.
    [Show full text]
  • Theory of an Immune System Retrovirus
    Proc. Nati. Acad. Sci. USA Vol. 83, pp. 9159-9163, December 1986 Medical Sciences Theory of an immune system retrovirus (human immunodeficiency virus/acquired immune deficiency syndrome) LEON N COOPER Physics Department and Center for Neural Science, Brown University, Providence, RI 02912 Contributed by Leon N Cooper, July 23, 1986 ABSTRACT Human immunodeficiency virus (HIV; for- initiates clonal expansion, sustained by interleukin 2 and y merly known as human T-cell lymphotropic virus type interferon. Ill/lymphadenopathy-associated virus, HTLV-Ill/LAV), the I first give a brief sketch of these events in a linked- retrovirus that infects T4-positive (helper) T cells of the interaction model in which it is assumed that antigen-specific immune system, has been implicated as the agent responsible T cells must interact with the B-cell-processed virus to for the acquired immune deficiency syndrome. In this paper, initiate clonal expansion (2). I then assume that virus-specific I contrast the growth of a "normal" virus with what I call an antibody is the major component ofimmune system response immune system retrovirus: a retrovirus that attacks the T4- that limits virus spread. As will be seen, the details of these positive T cells of the immune system. I show that remarkable assumptions do not affect the qualitative features of my interactions with other infections as well as strong virus conclusions. concentration dependence are general properties of immune Linked-Interaction Model for Clonal Expansion of Lympho- system retroviruses. Some of the consequences of these ideas cytes. Let X be the concentration of normal infecting virus are compared with observations.
    [Show full text]
  • Discovery of HTLV-1, the First Human Retrovirus, Its Unique Regulatory Mechanisms, and Insights Into Pathogenesis
    Oncogene (2005) 24, 5931–5937 & 2005 Nature Publishing Group All rights reserved 0950-9232/05 $30.00 www.nature.com/onc Discovery of HTLV-1, the first human retrovirus, its unique regulatory mechanisms, and insights into pathogenesis Mitsuaki Yoshida*,1 1Banyu Tsukuba Research Institute, Banyu Pharmaceutical Co., Ltd., 3 Ohkubo, Tsukuba, Ibaraki 300-2611, Japan I briefly review the discovery and characterization of the In Japan something was there, but it was not clear first human retrovirus, human T-cell leukemia virus type 1, focusing on contributions from Japanese researchers. Discovery of ATL The unique regulatory mechanisms for the viral regulation The first key event for human retrovirus was the with Tax and Rex, etiology of ATL and possible discovery of adult T-cell leukemia (ATL) by Kiyoshi leukemogenic mechanism with Tax are also discussed Takatsuki and his colleagues in Japan in 1976 (Uchi- briefly. et al Oncogene (2005) 24, 5931–5937. doi:10.1038/sj.onc.1208981 yama ., 1977). The reports from his laboratory described unique characteristics of the leukemia such as Keywords: HTLV-1; transcription; tumor-suppressor unusual morphology of leukemic cells with lobulated genes; cell cycle; epidemiology nuclei and surface phenotypes. The most striking feature of the disease was the Kyushu (West part of Japan) origin of most of the patients who were identified in Kyoto where Takatsuki’s group performed their research. Takatsuki’s findings were later confirmed by extensive epidemiology and a clear clustering of Introduction ATL cases in the Kyushu area strongly suggested a unique etiology (Hinuma et al., 1981a). At the time, When virologists and oncologists are challenged to this novel discovery elicited enormous attention from identify human tumor viruses, they dream of the physicians, virologists, epidemiologists and oncologists, contribution of such viruses towards understanding but still there was no clue as to how to search for an cancers and answering questions such as how and why etiology.
    [Show full text]
  • SIVISV.BOOK Layout 1
    SEDE Piattaforma FAD Nadirex http://nadirex.dnaconnect.sm ORGANIZING SECRETARIAT AND PROVIDER NR. 265 Nadirex International S.r.l. Via Riviera, 39 - 27100 Pavia Tel. +39.0382.525714 Fax. +39.0382.525736 Contact: Gloria Molla [email protected] mob. +39 347 8589333 Contact: Francesca Granata [email protected] www.nadirex.com www.congressosivsiv.com ORGANIZING COMMITTEE PRESIDENT Arnaldo Caruso (Brescia, Italy) CHAIRS Guido Antonelli (Rome, Italy) Franco Buonaguro (Naples, Italy) Arnaldo Caruso (Brescia, Italy) Massimiliano Galdiero (Naples, Italy) Giuseppe Portella (Naples, Italy) SCIENTIFIC SECRETARIAT Francesca Caccuri (Brescia, Italy) Rossana Cavallo (Turin, Italy) Massimo Clementi (Milan, Italy) Gianluigi Franci (Salerno, Italy) Maria Cristina Parolin (Padua, Italy) Alessandra Pierangeli (Rome, Italy) Luisa Rubino (Bari, Italy) Gabriele Vaccari (Rome, Italy) EXECUTIVE BOARD Guido Antonelli (Rome, Italy) Franco Buonaguro (Naples, Italy) Arnaldo Caruso (Brescia, Italy) Massimiliano Galdiero (Naples, Italy) Giuseppe Portella (Naples, Italy) 3 EXECUTIVE BOARD PRESIDENT Arnaldo Caruso (Brescia, Italy) VICE PRESIDENT Canio Buonavoglia, University of Bari (Bari, Italy) SECRETARY Giorgio Gribaudo, University of Turin (Turin, Italy) TREASURER Luisa Rubino, National Research Council (Bari, Italy) ADVISER Guido Antonelli, University of Rome “La Sapienza” (Rome, Italy) ADVISORY COUNCIL Elisabetta Affabris (Rome, Italy) Fausto Baldanti (Pavia, Italy) Lawrence Banks (Trieste, Italy) Roberto Burioni (Milan, Italy) Arianna Calistri
    [Show full text]
  • RNA Viruses As Tools in Gene Therapy and Vaccine Development
    G C A T T A C G G C A T genes Review RNA Viruses as Tools in Gene Therapy and Vaccine Development Kenneth Lundstrom PanTherapeutics, Rte de Lavaux 49, CH1095 Lutry, Switzerland; [email protected]; Tel.: +41-79-776-6351 Received: 31 January 2019; Accepted: 21 February 2019; Published: 1 March 2019 Abstract: RNA viruses have been subjected to substantial engineering efforts to support gene therapy applications and vaccine development. Typically, retroviruses, lentiviruses, alphaviruses, flaviviruses rhabdoviruses, measles viruses, Newcastle disease viruses, and picornaviruses have been employed as expression vectors for treatment of various diseases including different types of cancers, hemophilia, and infectious diseases. Moreover, vaccination with viral vectors has evaluated immunogenicity against infectious agents and protection against challenges with pathogenic organisms. Several preclinical studies in animal models have confirmed both immune responses and protection against lethal challenges. Similarly, administration of RNA viral vectors in animals implanted with tumor xenografts resulted in tumor regression and prolonged survival, and in some cases complete tumor clearance. Based on preclinical results, clinical trials have been conducted to establish the safety of RNA virus delivery. Moreover, stem cell-based lentiviral therapy provided life-long production of factor VIII potentially generating a cure for hemophilia A. Several clinical trials on cancer patients have generated anti-tumor activity, prolonged survival, and
    [Show full text]
  • The Role of Herpes Simplex Virus Type 1 Infection in Demyelination of the Central Nervous System
    International Journal of Molecular Sciences Review The Role of Herpes Simplex Virus Type 1 Infection in Demyelination of the Central Nervous System Raquel Bello-Morales 1,2,* , Sabina Andreu 1,2 and José Antonio López-Guerrero 1,2 1 Departamento de Biología Molecular, Universidad Autónoma de Madrid, Cantoblanco, 28049 Madrid, Spain; [email protected] (S.A.); [email protected] (J.A.L.-G.) 2 Centro de Biología Molecular Severo Ochoa, CSIC-UAM, Cantoblanco, 28049 Madrid, Spain * Correspondence: [email protected] Received: 30 June 2020; Accepted: 15 July 2020; Published: 16 July 2020 Abstract: Herpes simplex type 1 (HSV-1) is a neurotropic virus that infects the peripheral and central nervous systems. After primary infection in epithelial cells, HSV-1 spreads retrogradely to the peripheral nervous system (PNS), where it establishes a latent infection in the trigeminal ganglia (TG). The virus can reactivate from the latent state, traveling anterogradely along the axon and replicating in the local surrounding tissue. Occasionally, HSV-1 may spread trans-synaptically from the TG to the brainstem, from where it may disseminate to higher areas of the central nervous system (CNS). It is not completely understood how HSV-1 reaches the CNS, although the most accepted idea is retrograde transport through the trigeminal or olfactory tracts. Once in the CNS, HSV-1 may induce demyelination, either as a direct trigger or as a risk factor, modulating processes such as remyelination, regulation of endogenous retroviruses, or molecular mimicry. In this review, we describe the current knowledge about the involvement of HSV-1 in demyelination, describing the pathways used by this herpesvirus to spread throughout the CNS and discussing the data that suggest its implication in demyelinating processes.
    [Show full text]
  • Risk Groups: Viruses (C) 1988, American Biological Safety Association
    Rev.: 1.0 Risk Groups: Viruses (c) 1988, American Biological Safety Association BL RG RG RG RG RG LCDC-96 Belgium-97 ID Name Viral group Comments BMBL-93 CDC NIH rDNA-97 EU-96 Australia-95 HP AP (Canada) Annex VIII Flaviviridae/ Flavivirus (Grp 2 Absettarov, TBE 4 4 4 implied 3 3 4 + B Arbovirus) Acute haemorrhagic taxonomy 2, Enterovirus 3 conjunctivitis virus Picornaviridae 2 + different 70 (AHC) Adenovirus 4 Adenoviridae 2 2 (incl animal) 2 2 + (human,all types) 5 Aino X-Arboviruses 6 Akabane X-Arboviruses 7 Alastrim Poxviridae Restricted 4 4, Foot-and- 8 Aphthovirus Picornaviridae 2 mouth disease + viruses 9 Araguari X-Arboviruses (feces of children 10 Astroviridae Astroviridae 2 2 + + and lambs) Avian leukosis virus 11 Viral vector/Animal retrovirus 1 3 (wild strain) + (ALV) 3, (Rous 12 Avian sarcoma virus Viral vector/Animal retrovirus 1 sarcoma virus, + RSV wild strain) 13 Baculovirus Viral vector/Animal virus 1 + Togaviridae/ Alphavirus (Grp 14 Barmah Forest 2 A Arbovirus) 15 Batama X-Arboviruses 16 Batken X-Arboviruses Togaviridae/ Alphavirus (Grp 17 Bebaru virus 2 2 2 2 + A Arbovirus) 18 Bhanja X-Arboviruses 19 Bimbo X-Arboviruses Blood-borne hepatitis 20 viruses not yet Unclassified viruses 2 implied 2 implied 3 (**)D 3 + identified 21 Bluetongue X-Arboviruses 22 Bobaya X-Arboviruses 23 Bobia X-Arboviruses Bovine 24 immunodeficiency Viral vector/Animal retrovirus 3 (wild strain) + virus (BIV) 3, Bovine Bovine leukemia 25 Viral vector/Animal retrovirus 1 lymphosarcoma + virus (BLV) virus wild strain Bovine papilloma Papovavirus/
    [Show full text]
  • Introduction to Viroids and Prions
    Harriet Wilson, Lecture Notes Bio. Sci. 4 - Microbiology Sierra College Introduction to Viroids and Prions Viroids – Viroids are plant pathogens made up of short, circular, single-stranded RNA molecules (usually around 246-375 bases in length) that are not surrounded by a protein coat. They have internal base-pairs that cause the formation of folded, three-dimensional, rod-like shapes. Viroids apparently do not code for any polypeptides (proteins), but do cause a variety of disease symptoms in plants. The mechanism for viroid replication is not thoroughly understood, but is apparently dependent on plant enzymes. Some evidence suggests they are related to introns, and that they may also infect animals. Disease processes may involve RNA-interference or activities similar to those involving mi-RNA. Prions – Prions are proteinaceous infectious particles, associated with a number of disease conditions such as Scrapie in sheep, Bovine Spongiform Encephalopathy (BSE) or Mad Cow Disease in cattle, Chronic Wasting Disease (CWD) in wild ungulates such as muledeer and elk, and diseases in humans including Creutzfeld-Jacob disease (CJD), Gerstmann-Straussler-Scheinker syndrome (GSS), Alpers syndrome (in infants), Fatal Familial Insomnia (FFI) and Kuru. These diseases are characterized by loss of motor control, dementia, paralysis, wasting and eventually death. Prions can be transmitted through ingestion, tissue transplantation, and through the use of comtaminated surgical instruments, but can also be transmitted from one generation to the next genetically. This is because prion proteins are encoded by genes normally existing within the brain cells of various animals. Disease is caused by the conversion of normal cell proteins (glycoproteins) into prion proteins.
    [Show full text]
  • The Discovery of HTLV-1, the First Pathogenic Human Retrovirus John M
    PERSPECTIVE PERSPECTIVE The discovery of HTLV-1, the first pathogenic human retrovirus John M. Coffin1 Tufts University School of Medicine, Boston MA 02111 Edited by Peter K. Vogt, The Scripps Research Institute, La Jolla, CA, and approved November 11, 2015 (received for review November 2, 2015) After the discovery of retroviral reverse transcriptase in 1970, there was a flurry of activity, sparked by the “War on Cancer,” to identify human cancer retroviruses. After many false claims resulting from various artifacts, most scientists abandoned the search, but the Gallo laboratory carried on, developing both specific assays and new cell culture methods that enabled them to report, in the accompanying 1980 PNAS paper, identification and partial characterization of human T-cell leukemia virus (HTLV; now known as HTLV-1) produced by a T-cell line from a lymphoma patient. Follow-up studies, including collaboration with the group that first identified a cluster of adult T-cell leukemia (ATL) cases in Japan, provided conclusive evidence that HTLV was the cause of this disease. HTLV-1 is now known to infect at least 4–10 million people worldwide, about 5% of whom will develop ATL. Despite intensive research, knowledge of the viral etiology has not led to improvement in treatment or outcome of ATL. However, the technology for discovery of HTLV and acknowledgment of the existence of pathogenic human retroviruses laid the technical and intellectual foundation for the discovery of the cause of AIDS soon afterward. Without this advance, our ability to diagnose and treat HIV infection most likely would have been long delayed.
    [Show full text]
  • The History of Virology – the Scientific Study of Viruses and Therefore the Infections- Research Analysis of Virology and Retr
    Current research in Virology & Retrovirology 2021, Vol.2, Issue 3 Short Communication The history of virology – the scientific study of viruses and therefore the infections- Research Analysis of Virology and Retrovirology Kwanighee Yonsei University, South Korea cholerae. Bacteriophages were heralded as a possible treatment for Copyright: 2021 Kwanighee . This is an open-access article distributed diseases like typhoid and cholera, but their promise was forgotten under the terms of the Creative Commons Attribution License, which with the event of penicillin. Since the early 1970s, bacteria have permits unrestricted use, distribution, and reproduction in any medium, continued to develop resistance to antibiotics such as penicillin, provided the original author and source are credited. and this has led to a renewed interest in the use of bacteriophages to treat serious infections. Early research 1920–1940, D'Herelle Abstract travelled widely to market the utilization of bacteriophages within the treatment of bacterial infections. In 1928, he became professor The history of virology – the scientific study of viruses and therefore of biology at Yale and founded several research institutes. He was the infections they cause – began within the closing years of the convinced that bacteriophages were viruses despite opposition 19th century. Although Pasteur and Jenner developed the primary from established bacteriologists such as the Nobel Prize winner vaccines to guard against viral infections, they didn't know that Jules Bordet (1870–1961). Bordet argued that bacteriophages viruses existed. The first evidence of the existence of viruses came from experiments with filters that had pores sufficiently small to were not viruses but just enzymes released from "lysogenic" retain bacteria.
    [Show full text]
  • Chapter 6 - Virology Viruses in Action!!
    Chapter 6 - Virology Viruses in Action!! • Topics – Structure – Classification – Multiplication – Cultivation and replication – Nonviral infectious agent – Teratogenic/Oncogenic - Viruses have a host range. That is, viruses infect specific cells or tissues of specific hosts, or specific bacteria, Human or specific plants. Rhinovirus Common - Viral specificity refers to the specific Cold kinds of cells a virus can infect. It is regulated by the specificities of attachment, penetration and replication of the virus Properties of viruses A virion is an infectious virus particle - not all virus Viruses are not cells, do not have nuclei or particles are infectious mitochondria or ribosomes or other cellular Viruses are composed of a nucleic acid, RNA or DNA components. - never both . Viruses replicate or multiply. Viruses do not grow. All viruses have a protein coat or shell that surrounds Viruses replicate or multiply only within living cells. and protects the nucleic acid core. Viruses are obligate intracellular parasites . Some viruses have a lipid envelope or membrane surrounding a nucleocapsid core. The source of the The term virus was coined by Pasteur, and is from envelope is from the membranes of the host cell. the Latin word for poison. Some viruses package enzymes - e.g. RNA- Components of viruses - dependent-RNA polymerase or other enzymes - some do not package enzymes 1 Size comparison of viruses - how big are they? Structure • Size and morphology • Capsid • Envelope • Complex • Nucleic acid Mycoplasma? There are two major structures
    [Show full text]